# US Centers for Disease Control and Prevention

Type: government agency

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/us-centers-for-disease-control-and-prevention
Canonical HTML page: https://getbiobrief.com/entity/us-centers-for-disease-control-and-prevention

## Timeline

- **2026-07-11**: US aid worker tests positive — CDC confirms a US citizen aid worker in Congo has Ebola; contact tracing and containment measures initiated.
- **2026-07-10**: Record outbreak data confirmed — Africa CDC reports the outbreak as the fastest-growing ever at 1,830 confirmed cases and 648 deaths. U.S. aid worker infection announced by CDC.
- **2026-07-08**: Record outbreak confirmed — Africa CDC reports 1,830 confirmed cases and 648 deaths, marking the fastest-growing Ebola outbreak ever recorded on the continent.
- **2026-07-06**: Clinical trials for treatments launched — Researchers initiate a highly anticipated clinical study to test experimental therapies against the Bundibugyo virus.
- **2026-07-01**: Clinical trials for Ebola treatment begin — Researchers launch a highly anticipated study to test experimental therapies against the Bundibugyo strain.
- **2026-07**: Kenya court suspends U.S.-backed facility — A Kenyan court order halts construction of a U.S.-planned quarantine facility for Americans exposed abroad, complicating evacuation plans.
- **2026-06-15**: Kenya Ebola facility suspended — A Kenyan court orders suspension of construction on a US-backed isolation facility for exposed Americans, pausing Trump administration plans.
- **2026-05-22**: First US doctor infected — An American doctor working in Congo tests positive during outbreak's first week and is transferred to Germany for treatment.
- **2026-05-15**: Congo declares fresh Ebola outbreak — Authorities announce outbreak of Bundibugyo virus after weeks of undetected transmission, according to WHO.
- **2026-05-15**: Ebola outbreak officially declared — Congolese authorities declare a fresh Ebola outbreak after weeks of undetected transmission, as later confirmed by WHO.
- **2026-05**: First U.S. doctor infected and evacuated — An American doctor working in Congo tests positive for Ebola and is transferred to Germany for treatment during the outbreak’s first week.

## Recent coverage (3 stories)

### Bundibugyo Ebola Outbreak at 1,830 Cases Spurs Urgent Clinical Trials
2026-07-23 23:43:52 · Sentiment: Strongly negative · Impact: 8/10 · Sources: 2

With no approved vaccine or treatment, the rare Bundibugyo ebolavirus driving the Congo outbreak has infected 1,830 people and killed 648. As two U.S. workers fall ill, recently launched clinical trials represent the only hope for a therapeutic breakthrough.
Full story: https://getbiobrief.com/story/bundibugyo-ebola-outbreak-clinical-trials-begin

### 992-Case Cyclospora Spike Drives Demand for New Antiparasitic Drugs
2026-07-12 06:34:02 · Sentiment: Neutral · Impact: 5/10 · Sources: 6

With 992 infections in Michigan, the cyclospora outbreak creates urgent demand for antibiotic supplies and spotlights the need for novel antiparasitic therapies, presenting both short-term and long-term opportunities for biopharma.
Full story: https://getbiobrief.com/story/cyclospora-outbreak-biopharma-opportunity

### Ebola Bundibugyo Outbreak Hits 1,830 Cases: No Approved Vaccine, Trials Underway
2026-07-11 22:18:25 · Sentiment: Neutral · Impact: 6/10 · Sources: 2

The Congo Ebola outbreak driven by the rare Bundibugyo virus has ballooned to 1,830 cases with zero approved vaccines or treatments, forcing an urgent launch of clinical trials. For biotech and pharma, this emergency opens a race to develop broad-spectrum filovirus countermeasures.
Full story: https://getbiobrief.com/story/ebola-bundibugyo-outbreak-clinical-trials

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.